Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500110705Phase 4Not yet recruiting
Phase 4, randomised trial in postoperative pain comparing Ropivacaine + hydromorphone TAP block with Ropivacaine TAP block (2 arms). Primary endpoint: Time to first remedial analgesia. Planned start Oct 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500110705.